Fig. 4From: Interstitial lung disease occurring shortly after tocilizumab infusion in a patient with polyarticular juvenile idiopathic arthritis: a case reportClinical course of the patient after tocilizumab re-administration. NSAIDs non-steroidal anti-inflammatory drugs, PSL prednisolone, mPSL methylpredonisolone, TCZ tocilizumab, TAC tacrolimus, KL-6 Krebs von den Lungen-6, sc subcutaneousBack to article page